4//SEC Filing
Sigal Charles Elliott 4
Accession 0001628280-25-028902
CIK 0001706431other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 7:31 PM ET
Size
273.3 KB
Accession
0001628280-25-028902
Insider Transaction Report
Form 4
Sigal Charles Elliott
Director
Transactions
- Award
Common Stock
2025-05-30+8,000→ 31,806 total - Award
Stock Option (Right to Buy)
2025-05-30+16,000→ 16,000 totalExercise: $4.94From: 2026-05-30Exp: 2035-05-29→ Common Stock (16,000 underlying)
Holdings
- 10,000(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- [F2]The RSUs will vest in full on May 30, 2026.
- [F3]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F4]The shares subject to the stock option will vest and become exercisable in full on May 30, 2026.
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001661908
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 7:31 PM ET
- Size
- 273.3 KB